(Bloomberg) -- Mark Cuban is getting involved in generic drugs.
The Dallas Mavericks owner has attached his name to a company that will produce low-cost versions of expensive generic drugs. The Mark Cuban Cost Plus Drug Company pledges “to provide radical transparency” in how it prices its drugs.
The company will manufacture, distribute, and market its drugs to pharmacies and add a flat 15% margin to get its wholesale prices.
The first drug to be produced is albendazole, an anti-parasitic pill that can retail for over $400 per tablet. The company plans to make and distribute the drug for about $13, charge $15 as a wholesale price and set a manufacturer’s suggested retail price of $20 per tablet. The company is also donating 10,000 pills to researchers at the Baylor College of Medicine.
“This is our first step towards taking on the pricing of generic drugs,” Cuban tweeted Wednesday.
The new venture is hoping to introduce over 100 drugs by the end of 2021 and build a pharmaceutical factory in Dallas, Texas, by 2022.
Requests for comment from Cuban and the company were not returned.
Últimas Noticias
Debanhi Escobar: they secured the motel where she was found lifeless in a cistern
Members of the Specialized Prosecutor's Office in Nuevo León secured the Nueva Castilla Motel as part of the investigations into the case
The oldest person in the world died at the age of 119
Kane Tanaka lived in Japan. She was born six months earlier than George Orwell, the same year that the Wright brothers first flew, and Marie Curie became the first woman to win a Nobel Prize
Macabre find in CDMX: they left a body bagged and tied in a taxi
The body was left in the back seats of the car. It was covered with black bags and tied with industrial tape
The eagles of America will face Manchester City in a duel of legends. Here are the details
The top Mexican football champion will play a match with Pep Guardiola's squad in the Lone Star Cup
Why is it good to bring dogs out to know the world when they are puppies
A so-called protection against the spread of diseases threatens the integral development of dogs
